Cipla gets tentative approval for anti-AIDS drugs
According to information available on the USFDA website, the tentative approval is for 150 mg of Lamivedine and 300 mg for Zidovudine.
By PTI |
NEW DELHI: Indian pharmaceutical firm Cipla Ltd has received tentative approval from the US Food and Drugs Administration for anti HIV/AIDS drugs Lamivudine and Zidovudine.
According to information available on the USFDA website, the tentative approval is for 150 mg of Lamivedine and 300 mg for Zidovudine.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
